Author: Kerkar, P. G.; Naik, N.; Alexander, T.; Bahl, V. K.; Chakraborty, R. N.; Chatterjee, S. S.; Chopra, H. K.; Dani, S. I.; Deb, P. K.; Goswami, K. C.; Guha, S.; Gupta, R.; Gupta, V.; Hasija, P. K.; Jayagopal, P. B.; Justin Paul, G.; Kahali, D.; Katyal, V. K.; Khanna, N. N.; Mandal, M.; Mishra, S. S.; Mohanan, P. P.; Mullasari, A.; Mehta, S.; Pancholia, A. K.; Ray, S.; Roy, D.; Shanmugasundarm, S.; Sharma, S.; Singh, B. P.; Tewari, S.; Tyagi, S. K.; Venugopal, K. N.; Wander, G. S.; Yadav, R.; Das, M. K.
Title: Cardiological Society of India: Document on Acute MI care during COVID-19 Cord-id: q0cml3rz Document date: 2020_5_6
ID: q0cml3rz
Snippet: Abstract The unprecedented and rapidly spreading Coronavirus Disease-19 (COVID-19) pandemic has challenged public health care systems globally. Based on worldwide experience, India has initiated a nationwide lockdown to prevent the exponential surge of cases. During COVID-19, management of cardiovascular emergencies like acute Myocardial Infarction (MI) may be compromised. Cardiological Society of India (CSI) has ventured in this moment of crisis to evolve a consensus document for care of acute
Document: Abstract The unprecedented and rapidly spreading Coronavirus Disease-19 (COVID-19) pandemic has challenged public health care systems globally. Based on worldwide experience, India has initiated a nationwide lockdown to prevent the exponential surge of cases. During COVID-19, management of cardiovascular emergencies like acute Myocardial Infarction (MI) may be compromised. Cardiological Society of India (CSI) has ventured in this moment of crisis to evolve a consensus document for care of acute MI. However, this care should be individualized, based on local expertise and governmental advisories.
Search related documents:
Co phrase search for related documents- ace inhibitor and acute coronary syndrome: 1
- ace inhibitor and acute myocardial infarction: 1, 2
- ace inhibitor and low incidence: 1
- ace inhibitor and lung alveolar: 1
- ace inhibitor angiotensin receptor blocker and acute cardiac injury: 1
- ace inhibitor angiotensin receptor blocker and acute coronary syndrome: 1
- ace inhibitor angiotensin receptor blocker and acute myocardial infarction: 1
- acs acute coronary syndrome and acute coronary syndrome: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20, 21, 22, 23, 24, 25, 26, 27, 28, 29, 30, 31, 32, 33, 34, 35, 36, 37, 38, 39, 40, 41, 42, 43, 44, 45, 46, 47, 48, 49, 50, 51, 52, 53, 54, 55, 56, 57, 58, 59, 60, 61, 62, 63, 64, 65, 66, 67, 68, 69, 70, 71, 72
- acs acute coronary syndrome and acute myocardial infarction: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13
- acs acute coronary syndrome and low incidence: 1, 2, 3
- acs patient and acute coronary syndrome: 1, 2, 3, 4, 5, 6, 7
- acs patient and low incidence: 1
- acute cardiac injury and liver enzyme: 1
- acute cardiac injury and lopinavir ritonavir: 1, 2, 3, 4
- acute cardiac injury and lung alveolar: 1, 2
- acute coronary syndrome and lopinavir ritonavir: 1, 2
- acute coronary syndrome and low incidence: 1, 2, 3, 4, 5
Co phrase search for related documents, hyperlinks ordered by date